| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | REGENERON PHARMACEUTICALS, INC. | 8,838,240 | 8.2% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | REGENERON PHARMACEUTICALS, INC. | 10,317,407 | 9.6% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital World Investors | REGENERON PHARMACEUTICALS, INC. | 5,194,729 | 4.8% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | REGENERON PHARMACEUTICALS, INC. | 7,219,436 | 6.7% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | REGENERON PHARMACEUTICALS, INC. | 7,219,436 | 6.7% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | REGENERON PHARMACEUTICALS, INC. | 8,629,707 | 8.1% | EDGAR |
| SC 13D/A | 2023-09-27 | REGENERON PHARMACEUTICALS, INC. | Decibel Therapeutics, Inc. | 100 | 100.0% | EDGAR |
| SC 13D | 2023-08-18 | REGENERON PHARMACEUTICALS, INC. | Decibel Therapeutics, Inc. | 2,097,314 | 8.3% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital World Investors | REGENERON PHARMACEUTICALS, INC. | 6,315,819 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | REGENERON PHARMACEUTICALS, INC. | 11,096,984 | 10.4% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | REGENERON PHARMACEUTICALS, INC. | 8,722,448 | 8.2% | EDGAR |
| SC 13G/A | 2023-02-03 | BlackRock Inc. | REGENERON PHARMACEUTICALS, INC. | 9,166,817 | 8.6% | EDGAR |
| SC 13G | 2023-01-11 | JPMORGAN CHASE & CO | REGENERON PHARMACEUTICALS, INC. | 6,101,044 | 5.6% | EDGAR |
| SC 13G/A | 2022-10-11 | FMR LLC | REGENERON PHARMACEUTICALS, INC. | 10,809,746 | 10.1% | EDGAR |
| SC 13G/A | 2022-02-11 | REGENERON PHARMACEUTICALS, INC. | Intellia Therapeutics, Inc. | 3,702,995 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-11 | REGENERON PHARMACEUTICALS, INC. | Adverum Biotechnologies, Inc. | 1,809,098 | 1.8% | EDGAR |
| SC 13G/A | 2022-02-11 | Capital World Investors | REGENERON PHARMACEUTICALS, INC. | 5,391,870 | 5.1% | EDGAR |
| SC 13G | 2022-02-11 | REGENERON PHARMACEUTICALS, INC. | Decibel Therapeutics, Inc. | 2,097,314 | 8.4% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | REGENERON PHARMACEUTICALS, INC. | 8,158,515 | 7.7% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | REGENERON PHARMACEUTICALS, INC. | 10,062,965 | 9.5% | EDGAR |